Sporos Bioventures Appoints Dr. Rachel Humphrey to Board of Directors
HOUSTON–(BUSINESS WIRE)– Sporos Bioventures, LLC (“Sporos” or the “Company”), a private biotechnology company catalyzing the rapid development of breakthrough therapies through a portfolio of companies that target novel disease mechanisms in oncology and immune-related diseases, today announced the appointment of Rachel Humphrey, M.D. to its Board of Directors. “We are thrilled to welcome Rachel to …
Sporos Bioventures Appoints Dr. Rachel Humphrey to Board of Directors Read More »